The use of endotoxin neutralization as a biomarker for intestinal wall damage
AssigneeBioDtech, Inc.
InventorsMichael G. Pepe, Milton Keith Champion
Life of this patent
Estimating the term…
Abstract
Provided herein are methods for detecting endotoxin neutralization in a subject. Also provided are methods for determining the effectiveness of a therapeutic agent for treating intestinal wall damage. Further provided are methods of treating intestinal wall damage are also provided.
Claims24
A method of determining the effectiveness of a therapeutic agent for treating intestinal wall damage comprising:
- a) administering a therapeutic agent to the subject;
- b) adding exogenous endotoxin to a first biological sample from the subject after treatment with the therapeutic agent;
- c) detecting exogenous endotoxin in the sample from step b);
- d) determining the amount of undetected exogenous endotoxin in the first sample by subtracting the detected exogenous endotoxin from step c) from the total exogenous endotoxin added in step b);
- and
- e) calculating the percentage of total endotoxin neutralization in the first sample, wherein the percentage of total endotoxin neutralization is the percentage of undetected exogenous endotoxin of the total exogenous endotoxin, and wherein a decrease in total endotoxin neutralization in the first sample as compared to control indicates that the therapeutic agent is effective for treating intestinal wall damage.
A method of determining the effectiveness of a therapeutic agent for treating intestinal wall damage comprising:
- a) administering a therapeutic agent to the subject;
- b) heating a first biological sample from the subject after treatment with the therapeutic agent;
- c) adding a selected amount of exogenous endotoxin to the first sample of step b);
- d) detecting exogenous endotoxin in the first sample from step c);
- e) determining the amount of undetected exogenous endotoxin in the first sample by subtracting the detected exogenous endotoxin from step d) from the total exogenous endotoxin added in step c);
- f) acidifying a second biological sample from a subject after treatment with the therapeutic agent;
- g) adding the selected amount of exogenous endotoxin to the second sample of step f);
- h) detecting exogenous endotoxin in the second sample from step g);
- i) determining the amount of undetected exogenous endotoxin in the second sample by subtracting the detected exogenous endotoxin from step h) from the total exogenous endotoxin added in step g);
- and
- j) calculating a percentage of protein endotoxin neutralization, utilizing the following equation:
- ((amount of undetected exogenous endotoxin the second sample−amount of undetected exogenous endotoxin in the first sample)/selected amount of exogenous endotoxin)×100;
- wherein a decrease in the percentage of protein endotoxin neutralization after treatment as compared to a control indicates that the therapeutic agent is effective for treating intestinal wall damage.
A method of treating intestinal wall damage in a subject comprising:
- a) calculating levels of protein endotoxin neutralization, undetected exogenous endotoxin and enzymatic endotoxin neutralization in a biological sample from the subject;
- and
- b) calculating an endotoxin neutralization ratio using the following formula:
- (protein endotoxin neutralization+undetectable exogenous endotoxin)/enzymatic endotoxin neutralization)
- a ratio of about 5 or greater indicating that the subject has intestinal wall damage;
- and
- c) administering a therapeutic agent for treating intestinal wall damage to the subject.
(canceled)
(canceled)
(canceled)
24-27. (canceled)
Dependencies are inferred from the claim text.